Every Monday Is A Zecyte Monday
-
All men should be tested for prostate cancer.
-
True
-
False
-
Every Monday is a Zecyte Monday quiz focuses on prostate cancer diagnosis and treatment, debunking common misconceptions about PSA levels and the efficacy of radical prostatectomy. It also covers the recent approval of Zecyte for treating specific prostate cancer stages, enhancing learners' understanding of current medical protocols.
(71).webp "Every Monday Is A Zecyte Monday - Quiz")
Quiz Preview
- 2.
A PSA level under 4 ng/ml means that patient does not have prostate cancer
-
True
-
False
Correct Answer
A. FalseExplanation
A PSA level under 4 ng/ml does not necessarily mean that the patient does not have prostate cancer. While a PSA level under 4 ng/ml is generally considered normal, it does not completely rule out the possibility of prostate cancer. Other factors such as the patient's age, medical history, and symptoms should also be taken into consideration when determining the presence or absence of prostate cancer. Therefore, the statement that a PSA level under 4 ng/ml means the patient does not have prostate cancer is false.Rate this question:
-
- 3.
The PSA level reliably predicts who can get cured with prostate surgery (called radical prostatectomy)
-
True
-
False
Correct Answer
A. FalseExplanation
The PSA level is not a reliable predictor of who can get cured with prostate surgery. While a high PSA level may indicate the presence of prostate cancer, it does not guarantee that surgery will be successful in curing the disease. Other factors such as the stage and aggressiveness of the cancer, as well as the overall health of the patient, need to be considered when determining the effectiveness of surgery as a treatment option. Therefore, the statement is false.Rate this question:
-
- 4.
Abiraterone is indicated for chemo naïve hormone sensitive prostate cancer
-
True
-
False
Correct Answer
A. FalseExplanation
Abiraterone is not indicated for chemo-naïve hormone-sensitive prostate cancer. It is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC), either before or after chemotherapy. Therefore, the statement that Abiraterone is indicated for chemo-naïve hormone-sensitive prostate cancer is false.Rate this question:
-
- 5.
Recently zecyte has got DCGI approval for the treatment of chemo-naïve metastatic castrate resistant prostate cancer
-
True
-
False
Correct Answer
A. TrueExplanation
Zecyte has received approval from the Drug Controller General of India (DCGI) for treating chemo-naïve metastatic castrate resistant prostate cancer. This indicates that the statement is true.Rate this question:
-
- 6.
Guess the following diagnostic procedure
-
Rectal input examination
-
Finger rectal examination
-
Digital rectal examination
-
Digital prostate examination
Correct Answer
A. Digital rectal examinationExplanation
The correct answer is "Digital rectal examination." This procedure involves a doctor inserting a gloved, lubricated finger into the rectum to check for abnormalities in the rectum, prostate, and other nearby organs. It is commonly used to detect prostate cancer, evaluate rectal bleeding, and diagnose other conditions such as hemorrhoids or rectal tumors.Rate this question:
-
- 7.
Zecyte is _____________________inhibitor
-
CYP17
-
CYP450
-
CYP18
-
LEUTINIZING HORMONE
Correct Answer
A. CYP17Explanation
Zecyte is an inhibitor of CYP17. CYP17 is an enzyme involved in the production of androgens, which are male sex hormones. By inhibiting CYP17, Zecyte can effectively reduce the production of androgens, which is beneficial in the treatment of certain hormone-sensitive cancers such as prostate cancer.Rate this question:
-
- 8.
Recommended daily dose of zecyte is
-
1000 mg four times a day
-
250 mg four times a day
-
250 mg once daily
-
Both b and c
Correct Answer
A. 250 mg four times a dayExplanation
The recommended daily dose of Zecyte is 250 mg four times a day. This means that a total of 1000 mg of Zecyte should be taken in a day, with each dose being 250 mg. Taking the medication four times a day helps maintain a consistent level of the drug in the body, ensuring its effectiveness. Both options B and C suggest the correct dosage of 250 mg, but option B specifies the frequency of four times a day, making it the most accurate answer.Rate this question:
-
- 9.
Zecyte can be taken with food?
-
True
-
False
Correct Answer
A. FalseExplanation
Zecyte should not be taken with food. It is recommended to take Zecyte on an empty stomach, at least one hour before or two hours after a meal. Taking Zecyte with food may decrease its effectiveness and absorption into the body. Therefore, the correct answer is False.Rate this question:
-
- 10.
The target population for zecyte is
-
Chemo-naïve metastatic castrate resistant patients
-
Chemo-resistant metastatic castrate resistant patients
-
Both a and b
-
None of the above
Correct Answer
A. Both a and bExplanation
The target population for zecyte includes both chemo-naïve metastatic castrate resistant patients and chemo-resistant metastatic castrate resistant patients. This means that the medication is suitable for patients who have not received chemotherapy before as well as those who have previously received chemotherapy but are still experiencing metastatic castrate resistance.Rate this question:
-
Quiz Review Timeline (Updated): Oct 19, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
-
Current Version
-
Oct 19, 2023Quiz Edited by
ProProfs Editorial Team -
Sep 16, 2016Quiz Created by
Joshihardik17
Back to top